However, the clear drawback of cultivating cells as myoblasts or bone-marrow-derived MSCs is the limitation of their potential use in patients with acute myocardial infarction. In these patients ...

Although in other clinical scenarios most of those episodes are mostly related to coronary plaque rupture or other acute atherosclerotic plaque instability defining a type 1 myocardial infarction ...

SCS aligns with terminology for acute coronary syndromes, and helps to standardise the hierarchy of IHD endotypes, including ischaemia with no obstructive coronary artery disease (INOCA)3 and ...

The challenges of translating neuroprotective interventions with promising efficacy in animal studies into effective treatments for patients with stroke are well documented, with issues including ...

IV thrombolysis given within 4.5 hours of acute pontine infarction may significantly reduce neurological deterioration vs ...

New research provides further evidence that thrombolysis benefits select patients with acute ischemic stroke up to 24 hours after symptom onset.

Researchers continue to advance the science to determine best treatments for stroke. Based on an international study of 530 patients, researchers discovered that while the clot retrieval procedure ...

Portable point-of-care blood tests, done by EMS before hospital arrival, need validation but could guide treatment and ...

One in six deaths from cardiovascular disease in the United States is due to stroke, and over 100 million people worldwide have had a stroke, which is a leading cause of serious long-term disability.

and colleagues examined the potential of a new GFAP point-of-care test for rapidly distinguishing ICH from IS and stroke mimics in the prehospital phase in a study enrolling 353 patients with acute ...

People with brain bleeds had nearly 7 times higher blood levels of a specific brain protein, called glial fibrillary acidic protein (GFAP), than those who had strokes caused by clots in a study ...